$DUSA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DUSA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in DUSA PHARMACEUTICALS INC. Get notifications about new insider transactions in DUSA PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | WURZER DAVID M | Director | Option Exercise | D | 2.34 | 15,000 | 35,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | WURZER DAVID M | Director | Sell | U | 8.00 | 10,000 | 80,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | WURZER DAVID M | Director | Sell | U | 8.00 | 11,000 | 88,000 | 0 | 11 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 1.65 | 52,000 | 85,800 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 1.22 | 27,800 | 33,916 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 2.20 | 16,500 | 36,300 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 5.14 | 15,000 | 77,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 6.75 | 4,000 | 27,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 10.37 | 20,000 | 207,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | U | 8.00 | 133,200 | 1,065,600 | 0 | 133.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | U | 8.00 | 37,120 | 296,960 | 0 | 37.1 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Option Exercise | D | 1.65 | 85,000 | 140,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Option Exercise | D | 1.22 | 75,100 | 91,622 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Option Exercise | D | 2.20 | 19,500 | 42,900 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Option Exercise | D | 3.37 | 25,000 | 84,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Option Exercise | D | 6.90 | 50,000 | 345,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Sell | U | 8.00 | 219,150 | 1,753,200 | 0 | 219.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Sell | U | 8.00 | 53,560 | 428,480 | 0 | 53.6 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Option Exercise | D | 2.15 | 10,000 | 21,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Option Exercise | D | 3.08 | 10,000 | 30,800 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Option Exercise | D | 5.65 | 10,000 | 56,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Option Exercise | D | 9.30 | 10,000 | 93,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Option Exercise | D | 9.50 | 10,000 | 95,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Sell | U | 8.00 | 11,875 | 95,000 | 0 | 11.9 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Sell | U | 8.00 | 46,625 | 373,000 | 0 | 46.6 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 1.65 | 30,000 | 49,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 1.22 | 55,600 | 67,832 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 2.20 | 19,500 | 42,900 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 6.75 | 17,500 | 118,125 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 10.00 | 20,000 | 200,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | D | 9.92 | 22,500 | 223,200 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | U | 8.00 | 83,200 | 665,600 | 0 | 83.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | U | 8.00 | 29,919 | 239,352 | 0 | 29.9 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 1.65 | 55,000 | 90,750 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 1.22 | 54,600 | 66,612 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 2.20 | 16,500 | 36,300 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 6.75 | 15,000 | 101,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 10.00 | 20,000 | 200,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 9.92 | 22,500 | 223,200 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | U | 8.00 | 149,200 | 1,193,600 | 0 | 149.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | U | 8.00 | 61,014 | 488,112 | 0 | 61 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Hondros Paul J. | Director | Option Exercise | D | 2.34 | 15,000 | 35,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Hondros Paul J. | Director | Sell | U | 8.00 | 10,000 | 80,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Hondros Paul J. | Director | Sell | U | 8.00 | 6,000 | 48,000 | 0 | 6 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 1.65 | 130,000 | 214,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 1.22 | 187,400 | 228,628 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 2.20 | 28,500 | 62,700 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 3.37 | 60,000 | 202,200 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 6.75 | 50,000 | 337,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 15.90 | 50,000 | 795,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Option Exercise | D | 14.26 | 50,000 | 713,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Sell | U | 8.00 | 528,400 | 4,227,200 | 0 | 528.4 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Sell | U | 8.00 | 19,750 | 158,000 | 0 | 19.8 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Sell | U | 8.00 | 138,286 | 1,106,288 | 0 | 138.3 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 2.15 | 10,000 | 21,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 1.10 | 10,000 | 11,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 2.01 | 10,000 | 20,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 3.08 | 10,000 | 30,800 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 5.65 | 10,000 | 56,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 9.30 | 10,000 | 93,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Option Exercise | D | 9.50 | 10,000 | 95,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Sell | U | 8.00 | 13,750 | 110,000 | 0 | 13.8 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Sell | U | 8.00 | 34,500 | 276,000 | 0 | 34.5 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Sell | U | 8.00 | 50,250 | 402,000 | 0 | 50.3 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Option Exercise | D | 2.15 | 10,000 | 21,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Option Exercise | D | 1.10 | 10,000 | 11,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Option Exercise | D | 1.27 | 15,000 | 19,050 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Sell | U | 8.00 | 10,000 | 80,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Sell | U | 8.00 | 206,000 | 1,648,000 | 0 | 206 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 1.65 | 85,000 | 140,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 1.22 | 37,550 | 45,811 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 2.20 | 19,500 | 42,900 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 6.75 | 20,000 | 135,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 10.00 | 25,000 | 250,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 9.92 | 20,000 | 198,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | U | 8.00 | 209,150 | 1,673,200 | 0 | 209.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | U | 8.00 | 66,862 | 534,896 | 0 | 66.9 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 1.65 | 55,000 | 90,750 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 1.22 | 40,600 | 49,532 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 2.20 | 16,500 | 36,300 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 6.75 | 15,000 | 101,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 10.00 | 20,000 | 200,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Option Exercise | D | 9.92 | 25,000 | 248,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Sell | U | 8.00 | 149,200 | 1,193,600 | 0 | 149.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Sell | U | 8.00 | 39,085 | 312,680 | 0 | 39.1 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 2.15 | 10,000 | 21,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 1.10 | 10,000 | 11,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 2.01 | 10,000 | 20,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 3.08 | 10,000 | 30,800 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 5.65 | 10,000 | 56,500 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 9.30 | 10,000 | 93,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 9.50 | 10,000 | 95,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Option Exercise | D | 2.51 | 10,000 | 25,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Sell | U | 8.00 | 11,875 | 95,000 | 0 | 11.9 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Sell | U | 8.00 | 52,125 | 417,000 | 0 | 52.1 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ALTOMARI ALFRED | Director | Option Exercise | D | 2.34 | 15,000 | 35,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ALTOMARI ALFRED | Director | Sell | U | 8.00 | 10,000 | 80,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | ALTOMARI ALFRED | Director | Sell | U | 8.00 | 10,000 | 80,000 | 0 | 10 K to 0 (-100.00 %) |
Nov 13 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | M | 1.60 | 7,500 | 12,000 | 0 | |
Nov 13 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Buy | M | 1.60 | 7,500 | 12,000 | 276,012 | 268.5 K to 276 K (+2.79 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | WURZER DAVID M | Director | Grant | A | 0.00 | 8,000 | 0 | 21,000 | 13 K to 21 K (+61.54 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | MOLITEUS MAGNUS | Director | Grant | A | 0.00 | 8,000 | 0 | 58,500 | 50.5 K to 58.5 K (+15.84 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | Hondros Paul J. | Director | Grant | A | 0.00 | 8,000 | 0 | 16,000 | 8 K to 16 K (+100.00 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | HAFT JAY M | Director | Grant | A | 0.00 | 8,000 | 0 | 64,000 | 56 K to 64 K (+14.29 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | Casdin Alexander W. | Director | Grant | A | 0.00 | 8,000 | 0 | 216,000 | 208 K to 216 K (+3.85 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | BARTASH DAVID M | Director | Grant | A | 0.00 | 8,000 | 0 | 64,000 | 56 K to 64 K (+14.29 %) |
Jul 02 2012 | DUSA | DUSA PHARMACEUTICA ... | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 8,000 | 0 | 20,000 | 12 K to 20 K (+66.67 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 6.13 | 872 | 5,345 | 170,320 | 171.2 K to 170.3 K (-0.51 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Payment of Exercise | F | 6.13 | 1,030 | 6,314 | 272,710 | 273.7 K to 272.7 K (-0.38 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Payment of Exercise | F | 6.13 | 1,172 | 7,184 | 113,119 | 114.3 K to 113.1 K (-1.03 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 6.13 | 872 | 5,345 | 210,214 | 211.1 K to 210.2 K (-0.41 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Payment of Exercise | F | 6.13 | 1,506 | 9,232 | 666,686 | 668.2 K to 666.7 K (-0.23 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 6.13 | 1,030 | 6,314 | 268,512 | 269.5 K to 268.5 K (-0.38 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Payment of Exercise | F | 6.13 | 872 | 5,345 | 188,285 | 189.2 K to 188.3 K (-0.46 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | M | 1.60 | 17,500 | 28,000 | 0 | |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.84 | 1,600 | 9,344 | 211,086 | 212.7 K to 211.1 K (-0.75 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.81 | 800 | 4,648 | 212,686 | 213.5 K to 212.7 K (-0.37 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.80 | 5,224 | 30,299 | 213,486 | 218.7 K to 213.5 K (-2.39 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.76 | 1,900 | 10,944 | 218,710 | 220.6 K to 218.7 K (-0.86 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.75 | 7,976 | 45,862 | 220,610 | 228.6 K to 220.6 K (-3.49 %) |
Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | M | 1.60 | 17,500 | 28,000 | 228,586 | 211.1 K to 228.6 K (+8.29 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 5.86 | 2,203 | 12,910 | 171,192 | 173.4 K to 171.2 K (-1.27 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | CAROTA MARK | Vice President, Ope ... | Payment of Exercise | F | 5.86 | 2,203 | 12,910 | 189,157 | 191.4 K to 189.2 K (-1.15 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | ODell William F | Exec. VP Sales and ... | Payment of Exercise | F | 5.86 | 2,980 | 17,463 | 273,740 | 276.7 K to 273.7 K (-1.08 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 5.86 | 2,980 | 17,463 | 269,542 | 272.5 K to 269.5 K (-1.09 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 5.86 | 2,203 | 12,910 | 211,086 | 213.3 K to 211.1 K (-1.03 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | Doman Robert F | President and CEO | Payment of Exercise | F | 5.86 | 7,418 | 43,469 | 668,192 | 675.6 K to 668.2 K (-1.10 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | M | 3.87 | 6,250 | 24,188 | 0 | |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Option Exercise | M | 1.60 | 13,125 | 21,000 | 0 | |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Payment of Exercise | F | 5.86 | 2,507 | 14,691 | 114,291 | 116.8 K to 114.3 K (-2.15 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.78 | 200 | 1,156 | 116,798 | 117 K to 116.8 K (-0.17 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.75 | 48 | 276 | 116,998 | 117 K to 117 K (-0.04 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.76 | 9,287 | 53,493 | 117,046 | 126.3 K to 117 K (-7.35 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.77 | 700 | 4,039 | 126,333 | 127 K to 126.3 K (-0.55 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.79 | 548 | 3,173 | 127,033 | 127.6 K to 127 K (-0.43 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.81 | 600 | 3,486 | 127,581 | 128.2 K to 127.6 K (-0.47 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.83 | 148 | 863 | 128,181 | 128.3 K to 128.2 K (-0.12 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.82 | 1,648 | 9,591 | 128,329 | 130 K to 128.3 K (-1.27 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.80 | 3,148 | 18,258 | 129,977 | 133.1 K to 130 K (-2.36 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.85 | 1,048 | 6,131 | 133,125 | 134.2 K to 133.1 K (-0.78 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.84 | 52 | 304 | 134,173 | 134.2 K to 134.2 K (-0.04 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.90 | 100 | 590 | 134,225 | 134.3 K to 134.2 K (-0.07 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.87 | 100 | 587 | 134,325 | 134.4 K to 134.3 K (-0.07 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.88 | 148 | 870 | 134,425 | 134.6 K to 134.4 K (-0.11 %) |
Mar 14 2012 | DUSA | DUSA PHARMACEUTICA ... | MARCUS STUART L | VP, Sc. Aff & CMO | Sell | S | 5.84 | 100 | 584 | 134,573 | 134.7 K to 134.6 K (-0.07 %) |